VEGFA and ovarian carcinoma: In this study, the impact of circASH2L on the proliferation, invasion, lymphangiogenesis, and angiogenesis of ovarian cancer was analyzed both in vivo and in vitro. We found that circASH2L competes with VEGFA for binding to miR-665 to play an oncogenic role in ovarian cancer.